DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Lopes RD, Alings M, Connolly SJ. et al.
Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial.
Am Heart J 2017;
189: 137-145
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.